anmelden
SMI Expanded
1.948,90
PKT
+12,15
PKT
+0,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 10.02.22 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 10.02.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 10.02.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 10.02.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 09.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Equal-weight | Morgan Stanley | |
| 09.02.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 09.02.22 | ams-OSRAM Underweight | Barclays Capital | |
| 09.02.22 | ams-OSRAM Hold | Deutsche Bank AG | |
| 09.02.22 | Roche Buy | Deutsche Bank AG | |
| 09.02.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 09.02.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
| 09.02.22 | ams-OSRAM Neutral | Credit Suisse Group | |
| 08.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 08.02.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.02.22 | Swiss Re Underweight | Morgan Stanley | |
| 08.02.22 | Zurich Insurance Equal-weight | Morgan Stanley | |
| 08.02.22 | ams-OSRAM Neutral | UBS AG | |
| 08.02.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
| 07.02.22 | Holcim Hold | Jefferies & Company Inc. | |
| 07.02.22 | Roche Buy | Deutsche Bank AG | |
| 07.02.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 07.02.22 | Roche Overweight | Barclays Capital | |
| 07.02.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 07.02.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.22 | Roche Overweight | Barclays Capital | |
| 04.02.22 | Roche Neutral | UBS AG | |
| 04.02.22 | Nestlé Buy | UBS AG | |
| 04.02.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 04.02.22 | Givaudan Neutral | UBS AG | |
| 04.02.22 | Holcim Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.02.22 | Novartis Neutral | UBS AG | |
| 03.02.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 03.02.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.02.22 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.02.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research |